journal article·2018-11-12Open access

Core–shell microencapsulation of curcumin in PLGA microparticles: programmed for application in ovarian cancer therapy

Pankaj Dwivedi, Shuai Yuan, Shuya Han, Farhana Akbar Mangrio, Zhiqiang Zhu, Fan Lei, Zhang Ming, Lei Cheng, Zhongfa Liu, Ting Si, Ronald X. Xu

Abstract

In our study, we have established a novel liquid-driven co-flow focusing (LDCF) process to fabricate curcumin (CUR)-loaded poly (lactic-co-glycolic acid) (PLGA) microparticles (CPMs). LDCF-CPMs of size 20.26 ± 2.37 μm have high encapsulation efficiency (>70%) and were intended for application in ovarian cancer by intraperitoneal (IP) administration. LDCF-CPMs have smooth surface with narrow size distribution and a core-shell structured verified by confocal microscopy which can be precisely controlled by changing the flow rates of focusing, outer and inner phases. The LDCF-CPMs reveal the physiochemical stability with sustained release profile corresponding to 95% CUR release over a period of 14 days in an in vitro release medium. Moreover, LDCF-CPMs were testified for cytotoxicity against SKOV-3 ovarian cancer cell lines and peritoneal delivery advantages by animal experiments. The pharmacokinetics of LDCF-CPMs in rats following IP injection shows slow systemic absorption with mean residence time (MRT) of 13.54 h in comparison with 9.82 and 6.74 h for SE-CPMs and free CUR, respectively. In addition, IP delivery of CUR can expose the ovarian tumour to higher concentration for a longer duration by programming the thickness of the shell. The study provides compelling evidence for LDCF-CPMs having high therapeutic opportunity in the treatment of peritoneal cancers, such as ovarian, that reside in the peritoneal cavity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Curcumin's Biomedical Applications · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Precision Machinery and Precision Instrumentation, University of Science and Technology of China

Department of Biomedical Engineering, The Ohio State University

Department of Modern Mechanics, University of Science and Technology of China

First affiliated hospital of University of Science and Technology of China

College of Pharmacy, The Ohio State University

Funding

National Natural Science Foundation of China · Chinese Academy of Sciences

References (42)

Show source-provided references
1. 10.3322/caac.2120810.3322/caac.21208 ↗
2. 10.1016/j.ejca.2012.06.02610.1016/j.ejca.2012.06.026 ↗
3. 10.1016/j.canlet.2015.11.02110.1016/j.canlet.2015.11.021 ↗
4. 10.1124/mol.105.01740010.1124/mol.105.017400 ↗
5. 10.1073/pnas.88.12.529210.1073/pnas.88.12.5292 ↗
6. Kumar V, Lewis SA, Mutalik S, et al. Biodegradable microspheres of curcumin for treatment of inflammation. Indian J Physiol Pharmacol 2002;46:209–217.
7. 10.1016/j.ijpharm.2006.09.02510.1016/j.ijpharm.2006.09.025 ↗
8. 10.1080/1061186070134975210.1080/10611860701349752 ↗
9. Tonnesen HH. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie. 2002;57:820–824.
10. 10.1371/journal.pone.003261610.1371/journal.pone.0032616 ↗
11. 10.1039/c4ra15114c10.1039/c4ra15114c ↗
12. 10.3109/10717544.2014.93698810.3109/10717544.2014.936988 ↗
13. 10.1039/c5ra17599b10.1039/c5ra17599b ↗
14. 10.1182/blood-2006-02-00398810.1182/blood-2006-02-003988 ↗
15. 10.1158/1078-0432.CCR-08-002410.1158/1078-0432.CCR-08-0024 ↗
16. 10.1158/1078-0432.CCR-04-074410.1158/1078-0432.CCR-04-0744 ↗
17. Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7:1894–1900.
18. 10.1016/j.jconrel.2004.10.01510.1016/j.jconrel.2004.10.015 ↗
19. 10.1016/j.biomaterials.2005.12.02110.1016/j.biomaterials.2005.12.021 ↗
20. 10.1016/j.ijpharm.2006.06.02310.1016/j.ijpharm.2006.06.023 ↗
21. 10.1002/jps.2009410.1002/jps.20094 ↗
22. 10.1023/a:101890842143410.1023/a:1018908421434 ↗
23. 10.1016/S0169-409X(01)00219-810.1016/S0169-409X(01)00219-8 ↗
24. 10.1080/21691401.2017.136241510.1080/21691401.2017.1362415 ↗
25. 10.1103/PhysRevLett.80.28510.1103/PhysRevLett.80.285 ↗
26. 10.1002/smll.20050008710.1002/smll.200500087 ↗
27. 10.1016/j.ijpharm.2008.02.01210.1016/j.ijpharm.2008.02.012 ↗
28. 10.1016/j.ijpharm.2009.07.01710.1016/j.ijpharm.2009.07.017 ↗
29. 10.1017/S002211200900621110.1017/S0022112009006211 ↗
30. 10.1039/c5tb02402a10.1039/c5tb02402a ↗
31. 10.1039/C4LC01032A10.1039/C4LC01032A ↗
32. 10.1016/j.jconrel.2010.03.01410.1016/j.jconrel.2010.03.014 ↗
33. 10.1021/bm900541u10.1021/bm900541u ↗
34. 10.1371/journal.pone.013260910.1371/journal.pone.0132609 ↗
35. 10.1016/j.carbpol.2005.09.01810.1016/j.carbpol.2005.09.018 ↗
36. 10.1039/c5ra06982c10.1039/c5ra06982c ↗
37. 10.1021/jf803038f10.1021/jf803038f ↗
38. 10.1016/j.addr.2013.08.00310.1016/j.addr.2013.08.003 ↗
39. 10.1016/j.ejpb.2009.02.00210.1016/j.ejpb.2009.02.002 ↗
40. Yin Z, Sun J. Curcumin induces human SKOV3 cell apoptosis via the activation of Rho-kinase. Eur J Gynaecol Oncol. 2014;35:433–437.
41. 10.1007/s00280-015-2737-410.1007/s00280-015-2737-4 ↗
42. 10.1155/2013/72085810.1155/2013/720858 ↗